Some Teladoc (NASDAQ: TDOC) investors may be cursing the name Jeff Bezos this morning after seeing their stock dip.
But, has Amazon (NASDAQ: AMZN) actually just gifted them a great buying opportunity following the release of its telehealth competitor, Amazon Care, to employees nationwide?
Will Amazon kill Teladoc?
Add that question to the growing list of hypotheticals that have yet to come to pass:
- “Amazon Handmade will kill Etsy.”
- “Amazon Pharmacy will kill Big Pharma.”
- “Whole Foods will kill big-box retail.”
- “Prime Video will kill Netflix.”
The list goes ever on, and the answer is usually no, and here’s why:
- Firstly, Amazon Care launched 2 years ago — this isn’t new.
- Secondly, the e-commerce giant has only announced that Amazon Care will begin rolling out to its U.S.-based employees beginning in the summer, as well as some select employers — not exactly a game-changing event.
- Third and lastly, telemedicine is a relatively new industry that is expected to grow at a CAGR of almost 40% to reach $192 billion by 2025 from an estimated $39 billion in 2020. And if you think that’s not enough, the U.S. healthcare industry as a whole is worth closer to $9 trillion — with a ‘T’.
There’s plenty of business to go around when Amazon does eventually catch up, and despite its deep pockets, it has a long way to go before it can replicate its e-commerce and cloud success within the healthcare space. And don’t forget, Amazon is not invincible, as evidenced by the many companies it has not put in the ground with competitors — see list above.
So, in the words of the famous sci-fi author, Douglas Adams:
A MyWallSt subscription gives you access to over 100 market-beating stock picks and the research to back them up. Our analyst team post daily insights, subscriber-only podcasts and the headlines that move the market. Get your free access now!
MyWallSt operates a full disclosure policy. MyWallSt staff currently holds long positions in companies mentioned above. Read our full disclosure policy here.
Content Manager at MyWallSt
Jamie is the Content Editor here at MyWallSt. His favorite stock is Apple, which is also the first stock he ever bought. Jamie is not only a big fan of its products, but he believes that the tech giant has a whole lot more to give the world, and hasn't even scraped the surface of its potential.